Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Positive”

984 trials

Showing 20 of 984 results

Not applicableStudy completedNCT00000955
What this trial is testing

Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 864
Post-approval studies (Phase 4)Study completedNCT02864550
What this trial is testing

Oral Doxycycline for the Prevention of Syphilis in Men Who Have Sex with Men (DaDHS)

Who this might be right for
SyphilisSexually Transmitted Infections
British Columbia Centre for Disease Control 52
Not applicableUnknownNCT02025322
What this trial is testing

A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDS

Who this might be right for
HIV
Jury Candelario 36
Not applicableStudy completedNCT06666543
What this trial is testing

Becoming HIV-Exposed, Uninfected Children Born to HIV-Positive Mothers Followed at Bichat Claude Bernard Hospital

Who this might be right for
Virus-HIV
Assistance Publique - Hôpitaux de Paris 172
Post-approval studies (Phase 4)Study completedNCT01599364
What this trial is testing

Atazanavir/r + Lamivudine Dual Therapy

Who this might be right for
Human Immunodeficiency Virus
Catholic University of the Sacred Heart 266
Large-scale testing (Phase 3)Study completedNCT00130247
What this trial is testing

Tuberculosis Treatment Shortening Trial

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 394
Not applicableStudy completedNCT02038582
What this trial is testing

Strategies to Increase HIV Testing, Linkages to Care, and Male Circumcision in Africa

Who this might be right for
HIV
University of Washington 2,075
Testing effectiveness (Phase 2)Study completedNCT00000889
What this trial is testing

Evaluate the Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 72
Large-scale testing (Phase 3)Study completedNCT01404312
What this trial is testing

Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)

Who this might be right for
TuberculosisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 3,000
Not applicableStudy completedNCT01537367
What this trial is testing

Intervention to Retain HIV-positive Patients in Medical Care

Who this might be right for
Primary Care Appointment Keeping
Centers for Disease Control and Prevention 1,838
Not applicableStudy completedNCT00908011
What this trial is testing

Addition of Ezetimibe (Ezetrol®) to Ongoing Therapy With Rosuvastatin (Crestor®) in HIV Positive Patients Not Reaching Cholesterol Targets

Who this might be right for
HypercholesterolemiaHIV Infections
University of British Columbia 43
Not applicableStudy completedNCT00014053
What this trial is testing

Immune System Activity in Healthy Adults

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 48
Not applicableStudy completedNCT02119130
What this trial is testing

Quantiferon Gold Test for Detecting Tuberculosis (TB) Infection in HIV/AIDS Patients in South Africa

Who this might be right for
Latent TuberculosisHIV
Johns Hopkins University 3,506
Testing effectiveness (Phase 2)Active Not RecruitingNCT05122767
What this trial is testing

Rifapentine and Isoniazid TB Preventive Therapy (3HP) for Children Taking Dolutegravir-based Antiretroviral Treatment (DOLPHIN KIDS)

Who this might be right for
TuberculosisHIV
The Aurum Institute NPC 92
Early research (Phase 1)Study completedNCT00213005
What this trial is testing

Safety and Acceptability of Carraguard® in HIV Positive Women and Men

Who this might be right for
HIV Infections
Population Council 60
Not applicableStudy completedNCT01689545
What this trial is testing

Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU

Who this might be right for
HIV
Johns Hopkins Bloomberg School of Public Health 2,175
Post-approval studies (Phase 4)Ended earlyNCT02659761
What this trial is testing

Triumeq As an Integrase Single Tablet Regimen in People With HIV Who Inject Drugs

Who this might be right for
Human Immunodeficiency Virus
University College Dublin 33
Testing effectiveness (Phase 2)Study completedNCT00367458
What this trial is testing

Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT03809364
What this trial is testing

Pilot Test of a Couple-Based Medication Adherence Intervention for HIV-Positive Women and Their Male Partners in South Africa

Who this might be right for
Human Immunodeficiency Virus
University of Maryland, College Park 40
Large-scale testing (Phase 3)Study completedNCT00000949
What this trial is testing

Evaluate the Effects of Giving Proleukin (rIL-2) to HIV-Positive Patients With CD4 Counts Greater Than 300 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 460
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation